April 13, 2005
Small Minds
This just makes no sense. One day after concluding that breast implants remain too risky, because of lack of actual data in field trials, to permit their reintroduction, an FDA advisory panel voted 7-2 to permit a different manufacturer to resume their sale. FDA Panel OKs Implants [RedHerring.com]. Yesterday's decision was based on the rationale that the company, Mentor, had only three years' of test data. But today's approval of silicone devices from Inamed was based on only two years' testing.
BusinessWeek describes the debate as a "ball of confusion." I think it's more simple than that. Big breasts reduce men to small minds!
Posted by glenn
Comments